101 related articles for article (PubMed ID: 12969817)
1. Antioxidant enzyme expression in myelodysplastic and acute myeloid leukemia bone marrow: further evidence of a pathogenetic role for oxidative stress?
Bowen D; Wang L; Frew M; Kerr R; Groves M
Haematologica; 2003 Sep; 88(9):1070-2. PubMed ID: 12969817
[No Abstract] [Full Text] [Related]
2. [Cytomorphology of acute myeloid leukemia and myelodysplastic syndromes].
Kuriyama K
Rinsho Ketsueki; 2006 Aug; 47(8):701-9. PubMed ID: 16986708
[No Abstract] [Full Text] [Related]
3. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
4. Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.
Preisler HD
Cancer Treat Res; 2001; 108():185-230. PubMed ID: 11702600
[No Abstract] [Full Text] [Related]
5. Fluorescence in situ hybridization reveals closely correlated results in cytological and histological specimens of hematological neoplasias compared to conventional cytogenetics.
Gerr H; Gadzicki D; Kreipe H; Schlegelberger B; Wilkens L
Pathobiology; 2006; 73(6):271-9. PubMed ID: 17374964
[TBL] [Abstract][Full Text] [Related]
6. Novel valproic acid derivatives with potent differentiation-inducing activity in myeloid leukemia cells.
Deubzer H; Busche B; Rönndahl G; Eikel D; Michaelis M; Cinatl J; Schulze S; Nau H; Witt O
Leuk Res; 2006 Sep; 30(9):1167-75. PubMed ID: 16510182
[TBL] [Abstract][Full Text] [Related]
7. Shwachman-Diamond syndrome: an inherited model of aplastic anaemia with accelerated angiogenesis.
Leung EW; Rujkijyanont P; Beyene J; Wei K; Abdelhaleem M; Freedman MH; Dror Y
Br J Haematol; 2006 Jun; 133(5):558-61. PubMed ID: 16681645
[TBL] [Abstract][Full Text] [Related]
8. [Chromosome 11 rearrangements in the different haematological neoplasias].
Andreeva SV; Drozdova VD; Emel'ianenko LA
Tsitol Genet; 2007; 41(2):42-8. PubMed ID: 17494343
[TBL] [Abstract][Full Text] [Related]
9. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
[TBL] [Abstract][Full Text] [Related]
10. Faggot-like cells observed in acute myeloid leukemia with myelodysplasia-related changes mimicking acute promyelocytic leukemia.
Choi YW; Park JS; Jung YS; Cho SR
Leuk Lymphoma; 2015 Jun; 56(6):1906-7. PubMed ID: 25379617
[No Abstract] [Full Text] [Related]
11. Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia.
Tamura H; Dan K; Tamada K; Nakamura K; Shioi Y; Hyodo H; Wang SD; Dong H; Chen L; Ogata K
Clin Cancer Res; 2005 Aug; 11(16):5708-17. PubMed ID: 16115907
[TBL] [Abstract][Full Text] [Related]
12. Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes.
Travaglino E; Benatti C; Malcovati L; Della Porta MG; Gallì A; Bonetti E; Rosti V; Cazzola M; Invernizzi R
Eur J Haematol; 2008 Mar; 80(3):216-26. PubMed ID: 18081721
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow cells of myelodysplastic syndromes exhibit significant expression of apollon, livin and ILP-2 with reduction after transformation to overt leukemia.
Abe S; Yamamoto K; Hasegawa M; Inoue M; Kurata M; Hirokawa K; Kitagawa M; Nakagawa Y; Suzuki K
Leuk Res; 2005 Sep; 29(9):1095-6. PubMed ID: 16038738
[No Abstract] [Full Text] [Related]
14. Philadelphia chromosome positive myelodysplastic syndrome and acute myelogenous leukemia.
Advani AS
Leuk Res; 2004 Jun; 28(6):545-6. PubMed ID: 15120928
[No Abstract] [Full Text] [Related]
15. [Myelodysplastic syndrome / acute myeloid leukemia with t(8; 21) and bundle of Auer rods in neutrophils: an unusual hemopathy].
Kallel C; Makni F; Bouzidi H; Hdiji S; Elloumi M; Souissi T; Ellouz F
Ann Biol Clin (Paris); 2005; 63(4):429-32. PubMed ID: 16061442
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
17. The geldanamycin derivative 17-AAG decreases VEGF secretion and leukemia growth support by trisomy 8 myelodysplastic syndrome bone marrow stromal cells.
Hawkins LM; Narendran A
Pediatr Hematol Oncol; 2005 Mar; 22(2):115-25. PubMed ID: 15804996
[TBL] [Abstract][Full Text] [Related]
18. Oxidative DNA damage in bone marrow cells of patients with low-risk myelodysplastic syndrome.
Novotna B; Bagryantseva Y; Siskova M; Neuwirtova R
Leuk Res; 2009 Feb; 33(2):340-3. PubMed ID: 18687469
[TBL] [Abstract][Full Text] [Related]
19. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
[TBL] [Abstract][Full Text] [Related]
20. Myeloid malignancies: myelodysplastic syndromes, myeloproliferative disorders, and acute myeloid leukemia.
Wood BL
Clin Lab Med; 2007 Sep; 27(3):551-75, vii. PubMed ID: 17658407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
